Previously on 5/23/2017, Deutsche Bank released a statement for Agilent Technologies Inc. (NYSE:A) bumped up the target price from $58.00 to $62.00. At the time, this indicated a possible upside of 0.06%.
Recent Performance Chart
Agilent Technologies Inc. has one year low of $42.92 and a one year high of $66.77 with a price-earnings ratio of 34.32 and has a market capitalization of $0.
A total of 14 brokers have issued a report on the company. 6 firms rating the stock a strong buy, 4 firms rating the stock a buy, 6 brokerages rating the stock a hold, 0 equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a 12-month price target of $45.86.
General Company Details For Agilent Technologies Inc. (NYSE:A)
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent Crosslab Business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
The post A statement released earlier today by Jefferies & Co about Agilent Technologies Inc. (NYSE:A) bumps the target price to $66.00 appeared first on Octafinance.